EL7.AI
StocksMediumUpdated•Originally published 4 November 2026•Updated 4 November 2026•
1 min read

Dr Lal PathLabs Q2 Profit Jumps 27% as Board Declares Interim Dividend

Key Facts

1Dr Lal PathLabs reported a 27.4% year-on-year increase in consolidated net profit to Rs 193.9 crore for the July-September quarter.
2Total income for the period grew by 20.2 per cent to Rs 908.2 crore.
3The company's board announced a second interim dividend of Rs 5 per equity share.

Dr Lal PathLabs reported a 27.4% year-on-year increase in consolidated net profit to Rs 193.9 crore for the July-September quarter. Zee Business reported that the company's total income grew by 20.2% to reach Rs 908.2 crore during the same period.

The company's board declared a second interim dividend of Rs 5 per equity share, representing a 50% payout for the 2026-27 financial year. This profit growth occurred despite total expenses rising to Rs 647.6 crore from Rs 551.8 crore a year ago, reflecting the company's ongoing operational scale-up.

Latest Updates · 1

  1. Notable·

    Update: Financial results also showed that Dr Lal PathLabs' EBITDA grew by 25.1% during the second quarter. Total operating profit reached Rs 280 crore, further supporting the strong financial performance recorded by the company during the period ending September 2026.